跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Humulin 70/30 Kwikpen
Approved
STANDARD
Humulin 70/30 Kwikpen
Lilly France(Fegersheim)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1d9a6bc1ff846e02
Company
Lilly France(Fegersheim)
Type
Standard
Approval Details
Approval Id
1d9a6bc1ff846e02
Drug Approval Philippines Name
Humulin 70/30 Kwikpen
Product Name
Humulin 70/30 Kwikpen
Registration Number
BR-950
Brand Name
Humulin 70/30 Kwikpen
Generic Name
Insulin Human (rDNA)
Dosage Form
Suspension For Injection (S.C.)
Dosage Strength
100 IU/mL
Manufacturer
Lilly France(Fegersheim)
Importer
Zuelling Pharma Corporation
Distributor
Zuelling Pharma Corporation
Issuance Date
24 January 2024
Expiry Date
27 May 2029
Pharmacologic Category
Antidiabetics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1d9a6bc1ff846e02
Type
Standard
Back to Philippines FDA Approvals
Humulin 70/30 Kwikpen - Philippines FDA Drug Approval Details